A Longitudinal Study of Plasma pTau181 in Mild Cognitive Impairment with Lewy Bodies and Alzheimer's Disease.
Alan J ThomasCalum Alexander HamiltonAmanda HeslegraveSally BarkerRory DurcanSarah LawleyNicola BarnettDebbie LettMichael J FirbankGemma RobertsJohn-Paul TaylorPaul C DonaghyHenrik ZetterbergJohn O'BrienPublished in: Movement disorders : official journal of the Movement Disorder Society (2022)
pTau181 was not associated with an increased decline assessed using either baseline or repeat pTau181. pTau181 partially discriminated probable MCI-LB from controls and MCI-AD from controls but was not useful in distinguishing probable MCI-LB from MCI-AD. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.